State of regional lymph nodes and prognosis in stomach cancer

Cover Page

Abstract


Aim. Multiparameter analysis of the state of regional lymph nodes of stomach cancer to reveal prognostic criteria of patients’ 5-year survival.

Methods. The regional lymph nodes removed during surgery for stomach cancer in 170 oncologic patients were studied by means of histologic, immunohistochemical, electron microscopy and morphometric methods. The 5-year survival was calculated by the direct method.

Results. It was revealed that 5-year survival directly depends on the amount of involved lymph nodes. Detection of even single tumor cells in one regional lymph node worsens the prognosis for a patient’s life. The more metastases there are in lymph tissue, the worse the prognosis is. Immunomorphologic reactions and ultrastructural changes are of substantial significance. High 5-year survival was characteristic for hyperplasia of paracortical area with increased number of CD3(+) T-cells, the ultrastructure of which corresponds to activated (immune) lymphocytes, and for sinus histiocytosis as well with increased number of CD68(+) free macrophages in regional lymph nodes with pronounced phagocytic activity. Prognosis is worse in lymphoid follicular hyperplasia with high content of CD20(+) B-cells and plasmocytes. The lowest 5-year survival was accompanied by degenerative sinus histiocytosis, atrophy or sclerolipomatosis transformation of lymphoid tissue with hypoplasia of paracortical area and lymphoid follicles. Under an electron microscope active fibroblasts are seen synthesizing collagen and large number of degenerating cell forms, particularly, lymphocytes.

Conclusion. The 5-year survival of oncologic patients with stomach cancer is determined by the amount of metastatic regional lymph nodes, presence or absence of metastases, their volume in lymphoid tissue, histologic pattern and ultrastructural cell changes; comparative analysis of these criteria allows developing prognostic algorithm.


A B Bazhanov

Author for correspondence.
anton-bazhanov@yandex.ru
City Clinical Hospital №7 Kazan, Russia

D E Tsyplakov

anton-bazhanov@yandex.ru
Kazan State Medical University Kazan, Russia

  • Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2012 г. М.: Издательская группа РОНЦ. 2014; 226 с.
  • Бутенко А.В., Вашакмадзе Л.А., Белоус Т.А. и др. Выбор обьёма лимфаденэктомии у больных раком желудка в зависимости от фактора прогноза. Хирургия. Ж. им. Н.И. Пирогова. 2009; (4): 12-16.
  • Roukos D.H., Kappas A.M. Targeting the optimal extent of lymph node dissection for gastric cancer. J. Surg. Oncol. 2002; 81: 59-62. doi: 10.1002/jso.10153.
  • Жарков В.В., Михайлов И.В. Факторы прогноза при раке желудка. Мед. новости. 2005; (9): 17-21.
  • Хузин Ф.Ф., Цыплаков Д.Э. Прогностическое значение выявления скрытых микрометастазов в регионарных лимфатических узлах. Казанский мед. ж. 2010; (1): 69-72.
  • Цыплаков Д.Э., Добрынин В.А. Динамика и прогностическое значение морфологических изменений регионарных к раковой опухоли лимфатических узлов. Казанский мед. ж. 1989; (6): 453-456.
  • Цыплаков Д.Э., Бажанов А.Б. Морфометрическое и иммуногистохимическое исследование регионарных лимфатических узлов при раке желудка. Казанский мед. ж. 2015; (6): 971-978.
  • Цыплаков Д.Э., Бажанов А.Б. Электронно-микроскопический анализ регионарных лимфатических узлов в процессе развития рака. Казанский мед. ж. 2016; (1): 51-59. doi: 10.17750/KMJ2016-51.
  • Белянин В.Л., Цыплаков Д.Э. Диагностика реактивных гиперплазий лимфатических узлов. СПб., Казань: типография изд-ва «Чувашия». 1999; 328 с.
  • Стефанов С.Б. Морфометрическая сетка случайного шага как средство укоренного измерения элементов морфогенеза. Цитология. 1974; (6): 785-787.
  • Берёзкин Д.П. Изучение выживаемости и индивидуальный прогноз при злокачественных опухолях. В кн.: Общая онкология. Л.: Медицина. 1989; 608-631.
  • Ахметзянов Ф.Ш., Рувинский Д.М., Ахметзянова Ф.Ф., Каулгуд Х.А. Спленэктомия в хирургическом лечении рака желудка. Поволжский онкол. вестн. 2014; (2): 9-26.
  • Wu Z.Y., Li J.H., Zhan W.H., He Y.L. Lymph node micrometastasis and its correlation with MMP-2 expression in gastric carcinoma. World J. Gastroenterol. 2006; 12: 2941-2944. doi: 10.3748/wjg.v12.i18.2941.
  • Zheng Y., Wang L., Zhang J.P. et al. Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma. World J. Gastroenterol. 2010; 16: 339-344. doi: 10.3748/wjg.v16.i3.339.

Views

Abstract - 85

PDF (Russian) - 77


© 2017 Bazhanov A.B., Tsyplakov D.E.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.